In general, people start with the lowest dose and gradually increase it as instructed by their healthcare provider
But for researchers who want deeper protocol support, SeekPeptides members access personalized protocol builders, detailed weight-based dosing guides, and expert-reviewed titration schedules that account for individual factors like body weight, tolerance, and goals
Dysesthesia, an abnormal sensation often described as tingling, burning, or numbness in the skin, appeared in 8.8% of participants on the 9 mg dose and 20.9% on the 12 mg dose, compared to just 0.7% on placebo
The FDA-approved injectable form (Zepbound) has been studied in large clinical trials and shown to produce significant, sustained weight loss